In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...